Quick Answer
Verastem, Inc. reported R&D Expense of $114.60 million for fiscal year 2025.
Verastem, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $114.60M | +40.9% |
| 2024 | $81.33M | +32.6% |
| 2023 | $61.36M | +21.4% |
| 2022 | $50.56M | +28.5% |
| 2021 | $39.35M | -4.9% |
| 2020 | $41.38M | -9.6% |
| 2019 | $45.78M | +4.9% |
| 2018 | $43.65M | -6.0% |
| 2017 | $46.42M | +134.7% |
| 2016 | $19.78M | -51.2% |
| 2015 | $40.56M | +14.4% |
| 2014 | $35.45M | +36.7% |
| 2013 | $25.93M | +19.4% |
| 2012 | $21.71M | +119.7% |
| 2011 | $9.88M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $28.99M | +17.1% | +17.0% |
| June 30, 2025 | $24.79M | +37.2% | -15.0% |
| March 31, 2025 | $29.15M | +64.6% | +17.8% |
| September 30, 2024 | $24.75M | +77.5% | +37.1% |
| June 30, 2024 | $18.06M | +40.1% | +2.0% |
| March 31, 2024 | $17.71M | +47.4% | +27.0% |
| September 30, 2023 | $13.95M | +23.5% | +8.2% |
| June 30, 2023 | $12.89M | -13.4% | +7.3% |
- Verastem, Inc. showed an increase of +40.9% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2025 period, Verastem, Inc.’s r&d expense has grown by 1059.6% (from $9.88 million to $114.60 million).
- The most recent figure is from Verastem, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: